ORAGENICS, INC. Repayments of Short-term Debt
ORAGENICS, INC. (OGEN) reported Repayments of Short-term Debt of $227.35 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfShortTermDebt · last filed 2026-08-13
- ORAGENICS, INC. repayments of short-term debt for the quarter ending 2026-06-30 was $56.13K, a 57.78% decline year-over-year.
- ORAGENICS, INC. repayments of short-term debt for the quarter ending 2026-03-31 was $171.21K, a 12.45% decline year-over-year.
- ORAGENICS, INC. repayments of short-term debt for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- ORAGENICS, INC. repayments of short-term debt for the quarter ending 2025-09-30 was $3.00M, a 2451.45% increase year-over-year.
- ORAGENICS, INC. repayments of short-term debt for fiscal 2025 was $3.33M, a 380.23% increase from fiscal 2024.
- ORAGENICS, INC. repayments of short-term debt for fiscal 2024 was $693.11K, a 22.45% increase from fiscal 2023.
- ORAGENICS, INC. repayments of short-term debt for fiscal 2023 was $566.05K, a 0.33% increase from fiscal 2022.
- ORAGENICS, INC. repayments of short-term debt for fiscal 2022 was $564.21K, a 7.47% increase from fiscal 2021.
| Period end | Repayments of Short-term Debt 3 month | Repayments of Short-term Debt 6 month | Repayments of Short-term Debt 9 month | Repayments of Short-term Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | $56.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $227.35K 10-Q · filed 2026-08-13 | $227.35K derived: sum of 3 quarters · filed 2026-08-13 | $3.23M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $171.21K 10-Q · filed 2026-05-08 | $171.21K derived: sum of 2 quarters · filed 2026-05-08 | $3.17M derived: sum of 3 quarters · filed 2026-05-08 | $3.30M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $3.00M derived: sum of 2 quarters · filed 2026-03-16 | $3.13M derived: sum of 3 quarters · filed 2026-08-13 | $3.33M 10-K · filed 2026-03-16 |
| 2025-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $3.13M derived: sum of 2 quarters · filed 2026-08-13 | $3.33M 10-Q · filed 2025-11-07 | $3.59M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $132.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $328.53K 10-Q · filed 2026-08-13 | $591.35K derived: sum of 3 quarters · filed 2026-08-13 | $708.93K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $195.56K 10-Q · filed 2026-05-08 | $458.39K derived: sum of 2 quarters · filed 2026-05-08 | $575.97K derived: sum of 3 quarters · filed 2026-05-08 | $702.81K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $262.83K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $380.41K derived: sum of 2 quarters · filed 2026-03-16 | $507.25K derived: sum of 3 quarters · filed 2026-03-16 | $693.11K 10-K · filed 2026-03-16 |
| 2024-09-30 | $117.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $244.42K derived: sum of 2 quarters · filed 2025-11-07 | $430.28K 10-Q · filed 2025-11-07 | $611.00K derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $126.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $312.70K 10-Q · filed 2025-08-08 | $493.42K derived: sum of 3 quarters · filed 2025-08-08 | $611.11K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $185.86K 10-Q · filed 2025-05-09 | $366.58K derived: sum of 2 quarters · filed 2025-05-09 | $484.27K derived: sum of 3 quarters · filed 2025-05-09 | $592.16K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $180.72K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $298.41K derived: sum of 2 quarters · filed 2025-03-14 | $406.30K derived: sum of 3 quarters · filed 2025-03-14 | $566.05K 10-K · filed 2025-03-14 |
| 2023-09-30 | $117.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $225.58K derived: sum of 2 quarters · filed 2024-11-13 | $385.33K 10-Q · filed 2024-11-13 | $542.61K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $107.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $267.64K 10-Q · filed 2024-08-09 | $424.92K derived: sum of 3 quarters · filed 2024-08-09 | $528.43K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $159.75K 10-Q · filed 2024-05-15 | $317.03K derived: sum of 2 quarters · filed 2024-05-15 | $420.54K derived: sum of 3 quarters · filed 2024-05-15 | $542.71K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $157.28K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $260.79K derived: sum of 2 quarters · filed 2024-03-29 | $382.96K derived: sum of 3 quarters · filed 2024-03-29 | $564.21K 10-K · filed 2024-03-29 |
| 2022-09-30 | $103.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $225.68K derived: sum of 2 quarters · filed 2023-11-09 | $406.92K 10-Q · filed 2023-11-09 | $585.76K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $122.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $303.42K 10-Q · filed 2023-08-11 | $482.26K derived: sum of 3 quarters · filed 2023-08-11 | $600.17K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $181.24K 10-Q · filed 2023-05-12 | $360.08K derived: sum of 2 quarters · filed 2023-05-12 | $477.99K derived: sum of 3 quarters · filed 2023-05-12 | $592.88K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $178.84K derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-04-17 | $296.75K derived: sum of 2 quarters · filed 2023-04-17 | $411.63K derived: sum of 3 quarters · filed 2023-04-17 | $524.98K 10-K · filed 2023-04-17 |
| 2021-09-30 | $117.91K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2023-04-14 | $232.79K derived: sum of 2 quarters · filed 2023-04-14 | $346.14K 10-Q/A · filed 2023-04-14 | $457.97K derived: sum of 4 quarters · filed 2023-04-14 |
| 2021-06-30 | $114.88K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2023-04-14 | $228.23K 10-Q/A · filed 2023-04-14 | $340.06K derived: sum of 3 quarters · filed 2023-04-14 | $413.78K derived: sum of 4 quarters · filed 2023-04-14 |
| 2021-03-31 | $113.35K 10-Q/A · filed 2023-04-14 | $225.18K derived: sum of 2 quarters · filed 2023-04-14 | $298.90K derived: sum of 3 quarters · filed 2023-04-14 | $369.75K derived: sum of 4 quarters · filed 2023-04-14 |
| 2020-12-31 | $111.83K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-29 | $185.56K derived: sum of 2 quarters · filed 2022-07-29 | $256.40K derived: sum of 3 quarters · filed 2022-07-29 | $329.42K 10-K/A · filed 2022-07-29 |
| 2020-09-30 | $73.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $144.57K derived: sum of 2 quarters · filed 2021-11-15 | $217.59K 10-Q · filed 2021-11-15 | $291.14K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $70.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $143.86K 10-Q · filed 2021-08-16 | $217.42K derived: sum of 3 quarters · filed 2021-08-16 | $267.42K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $73.02K 10-Q · filed 2021-05-03 | $146.57K derived: sum of 2 quarters · filed 2021-05-03 | $196.57K derived: sum of 3 quarters · filed 2021-05-03 | $261.57K derived: sum of 4 quarters · filed 2021-05-03 |
| 2019-12-31 | $73.56K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $123.55K derived: sum of 2 quarters · filed 2021-03-01 | $188.55K derived: sum of 3 quarters · filed 2021-03-01 | $252.93K 10-K · filed 2021-03-01 |
| 2019-09-30 | $50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $115.00K derived: sum of 2 quarters · filed 2020-11-10 | $179.37K 10-Q · filed 2020-11-10 | $245.56K derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $129.38K 10-Q · filed 2020-08-14 | $195.57K derived: sum of 3 quarters · filed 2020-08-14 | |
| 2019-03-31 | $64.38K 10-Q · filed 2020-05-15 | $130.57K derived: sum of 2 quarters · filed 2020-05-15 | ||
| 2018-12-31 | $66.19K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | $200.75K 10-K · filed 2020-03-04 | ||
| 2018-09-30 | $134.56K 10-Q · filed 2019-11-14 | |||
| 2014-12-31 | $44.72K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $79.24K derived: sum of 2 quarters · filed 2015-02-27 | $123.79K derived: sum of 3 quarters · filed 2015-02-27 | $158.21K 10-K · filed 2015-02-27 |
| 2014-09-30 | $34.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-03 | $79.07K derived: sum of 2 quarters · filed 2014-11-03 | $113.49K 10-Q · filed 2014-11-03 | $157.63K derived: sum of 4 quarters · filed 2015-02-27 |
| 2014-06-30 | $44.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $78.97K 10-Q · filed 2014-08-07 | $123.11K derived: sum of 3 quarters · filed 2015-02-27 | $157.20K derived: sum of 4 quarters · filed 2015-02-27 |
| 2014-03-31 | $34.42K 10-Q · filed 2014-05-09 | $78.56K derived: sum of 2 quarters · filed 2015-02-27 | $112.65K derived: sum of 3 quarters · filed 2015-02-27 | $144.62K derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-12-31 | $44.14K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $78.23K derived: sum of 2 quarters · filed 2015-02-27 | $110.20K derived: sum of 3 quarters · filed 2015-02-27 | $140.93K 10-K · filed 2015-02-27 |
| 2013-09-30 | $34.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-03 | $66.06K derived: sum of 2 quarters · filed 2014-11-03 | $96.79K 10-Q · filed 2014-11-03 | $137.30K derived: sum of 4 quarters · filed 2014-11-03 |
| 2013-06-30 | $31.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $62.70K 10-Q · filed 2014-08-07 | $103.22K derived: sum of 3 quarters · filed 2014-08-07 | |
| 2013-03-31 | $30.73K 10-Q · filed 2014-05-09 | $71.25K derived: sum of 2 quarters · filed 2014-05-09 | ||
| 2012-12-31 | $40.52K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $140.03K 10-K · filed 2014-02-28 | ||
| 2012-09-30 | $99.51K 10-Q · filed 2013-10-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |